The use of asciminib versus ponatinib for multiresistant CML VJHemOnc – Video Journal of Hematology & HemOnc 2:51 2 years ago 1 263 Далее Скачать
Ponatinib versus ascimininib in the third-line treatment of CML VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 509 Далее Скачать
Managing drug resistance in CP-CML with ponatinib and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 1:08 1 year ago 151 Далее Скачать
Asciminib versus other TKIs in the frontline treatment of CML: the ASC4FIRST study VJHemOnc – Video Journal of Hematology & HemOnc 1:46 7 months ago 407 Далее Скачать
Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs in the third-line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:49 1 year ago 150 Далее Скачать
Management of Thrombosis Risk with Ponatinib and other TKIs for CML? HMP Education 24:30 9 years ago 1 261 Далее Скачать
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 185 Далее Скачать
Phase I study of asciminib in patients with CP-CML carrying the T315I mutation VJHemOnc – Video Journal of Hematology & HemOnc 1:03 2 years ago 497 Далее Скачать
Mechanisms of resistance to the TKI asciminib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:16 3 months ago 90 Далее Скачать
Ponatinib for CML and Ph+ ALL: five-year results from the PACE trial VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 447 Далее Скачать
Jorge Cortes, MD, Shares Data on Asciminib Versus TKIs in CML Blood Cancers Today 8:00 6 months ago 386 Далее Скачать
Could asciminib be the new breakthrough in the treatment of CML? VJHemOnc – Video Journal of Hematology & HemOnc 2:42 3 weeks ago 119 Далее Скачать
Decitabine, venetoclax and ponatinib in patients with advanced CML and Ph+ AML VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 563 Далее Скачать
Targeting TKI-resistant CML with LY3009120 and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 2:40 3 years ago 387 Далее Скачать
ASCEMBL: asciminib versus bosutinib in third-line treatment of CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 2:27 11 months ago 217 Далее Скачать
An overview of trials investigating asciminib in the treatment of Ph+ CML VJHemOnc – Video Journal of Hematology & HemOnc 6:31 10 months ago 409 Далее Скачать
Differences between CML in children and adults & the potential of asciminib in pediatric patients VJHemOnc – Video Journal of Hematology & HemOnc 3:19 1 year ago 233 Далее Скачать
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 2 years ago 539 Далее Скачать
